1. (a)Briefly describe the case study. What is it about?

(b)What do you learn about access to vaccines in low and low-middle-income countries?

(c) List two obstacles (mentioned in the case study) that low and middle-income countries face during epidemics?

1. (a)What kind of decision-making was the CEO of Serum India faced with? Can you identify the ethical dilemma he faced?

(b) How did Serum institute solve this? What kind of risks did he put his own family and fortune, his business?

(c)List two features of his response to the pandemic and why was it a difficult choice. What choices were made for accelerating production, and what kind of pricing policy decisions were made.

1. (a)The company CEO said that the company did not want to only set its eyes on profit. Was he right? Do you believe him and agree with him?

(b) While we discuss his business decision, our focus really is on ethical decision-making. How should pharma price their medicine? (c) Can you make one suggestion on how you would react if you were the CEO of the vaccine unit